AHCO

AdaptHealth Corp. is a provider of patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. It operates in 50 states through its network of over 670 locations in 47 states.

Wall Street analysts forecast AHCO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AHCO is 13.67 USD with a low forecast of 13.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Adapthealth Corp revenue for the last quarter amounts to 820.31M USD, increased 1.79 % YoY.

Adapthealth Corp. EPS for the last quarter amounts to 0.16 USD, increased 6.67 % YoY.

Adapthealth Corp (AHCO) has 10500 emplpoyees as of December 16 2025.

Today AHCO has the market capitalization of 1.39B USD.